Clinical Trial Update: Anifrolumab Real-world Treatment Outcomes in Systemic Lupus Erythematosus

View source ↗

Summary

A real-world study evaluating the outcomes of anifrolumab for systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Anifrolumab (anifrolumab)

Snippet

Sponsor: AstraZeneca | Conditions: Lupus Erythematosus, Systemic | Status: RECRUITING